CymaBay Therapeutics, Inc. / Insider Transactions
Source | Name | Title | Transaction Date | Shares | Price | Value |
|
---|---|---|---|---|---|---|---|
| Dorling Janet | N/A |
|
|
|
| |
| McWherter Charles | President of R&D |
|
|
|
| |
| Menold Daniel | Vice President, Finance |
|
|
|
| |
| Quinlan Paul T | General Counsel |
|
|
|
| |
| Dorling Janet | N/A |
|
|
|
| |
| McWherter Charles | President of R&D |
|
|
|
| |
| Menold Daniel | Vice President, Finance |
|
|
|
| |
| Quinlan Paul T | General Counsel |
|
|
|
| |
| Dorling Janet | N/A |
|
|
|
| |
| Shah Sujal | Chief Executive Officer |
|
|
|
| |
| McWherter Charles | President of R&D |
|
|
|
| |
| Quinlan Paul T | General Counsel |
|
|
|
| |
| Shah Sujal | Chief Executive Officer |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| McWherter Charles | President of R&D |
|
|
|
| |
| Quinlan Paul T | General Counsel |
|
|
|
| |
| McWherter Charles | President of R&D |
|
|
|
| |
| Quinlan Paul T | General Counsel |
|
|
|
| |
| Menold Daniel | Vice President, Finance |
|
|
|
| |
| McWherter Charles | President of R&D |
|
|
|
| |
| Quinlan Paul T | General Counsel |
|
|
|
| |
| Quinlan Paul T | General Counsel |
|
|
|
| |
| McWherter Charles | President of R&D |
|
|
|
| |
| McWherter Charles | President of R&D |
|
|
|
| |
| Quinlan Paul T | General Counsel |
|
|
|
| |
| KIM DENNIS D | Chief Medical Officer |
|
|
|
| |
| KIM DENNIS D | Chief Medical Officer |
|
|
|
| |
| Shah Sujal | Chief Executive Officer |
|
|
|
| |
| KIM DENNIS D | Chief Medical Officer |
|
|
|
| |
| Shah Sujal | Chief Executive Officer |
|
|
|
| |
| Shah Sujal | Chief Executive Officer |
|
|
|
| |
| Shah Sujal | Chief Executive Officer |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| Shah Sujal | Chief Executive Officer |
|
|
|
| |
| Shah Sujal | Chief Executive Officer |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| Shah Sujal | Chief Executive Officer |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| McWherter Charles | SVP & Chief Scientific Officer |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| Wills Robert James | N/A |
|
|
|
| |
| McWherter Charles | SVP & Chief Scientific Officer |
|
|
|
| |
| Shah Sujal | Interim President & CEO |
|
|
|
| |
| EMSTER KURT VON | N/A |
|
|
|
| |
| Wills Robert James | N/A |
|
|
|
| |
| McWherter Charles | Sr. Vice President |
|
|
|
| |
| OMara Patrick J. | VP, Business Development |
|
|
|
| |
| Shah Sujal | Chief Financial Officer |
|
|
|
| |
| GOLDFISCHER CARL | N/A |
|
|
|
| |
| von Emster Kurt | N/A |
|
|
|
| |
| von Emster Kurt | N/A |
|
|
|
| |
| Shah Sujal | Chief Financial Officer |
|
|
|
| |
| Van Wart Harold | President and CEO |
|
|
|
| |
| McWherter Charles | Sr. Vice President |
|
|
|
|